A recent editorial published in Clinical & Experimental Allergy highlights the limitations of current adult food allergy and hypersensitivity services, which are often fragmented due to a focus on organ systems or immunological mechanisms (e.g., IgE-mediated vs non-IgE-mediated) rather than

A recent article published in Paediatric Allergy and Immunology explores how adolescents experience and manage food allergies, particularly during the transition from being supported by parents to managing their allergies independently. Although the risk of fatalities from food allergy-related anaphylaxis

Anaphylaxis can have a devastating emotional impact on individuals and/or families when it results in a fatal or near-fatal event. Anaphylaxis UK, in collaboration with the University of Surrey, is conducting a service evaluation to better understand how healthcare professionals

A new consensus report on anaphylaxis has been published in The Journal of Allergy and Clinical Immunology by the Global Allergy and Asthma Excellence Network (GA2LEN). This report, developed by an international panel of 46 experts from 14 countries, addresses

A recent study published in Allergy examined real-world safety data on allergen immunotherapy (AIT) in adults with respiratory allergies. The study followed 1,545 patients—using both sublingual (SLIT) and subcutaneous (SCIT) routes—across eight European countries. Adverse events were recorded in 7.4% of patients,

A new systematic review published in Clinical and Translational Allergy examines the potential of epicutaneous immunotherapy (EPIT) for treating food allergies. The study, conducted by researchers from Tampere University and Imperial College London, analysed data from 11 randomised controlled trials

A recent study led by researchers at the RIKEN Centre for Integrative Medical Sciences (IMS) in Japan has provided new insights into the relationship between gut bacteria and food allergies, particularly to eggs. The findings suggest that certain types of

A Phase 1 clinical trial led by Imperial College London has tested a novel vaccine, VLP Peanut, designed to offer long-term protection against peanut allergy. Early results suggest the vaccine is well tolerated, reduces allergic responses, and promotes immune tolerance.

In celebration of #WorldAllergyWeek, and as the NHS celebrates its 70th Birthday #NHS70, we are sharing stories from our Healthcare Professional Members about their work. Professor Aziz Shiekh specialises in the field of epidemiology, the study of how often diseases occur in